Biogen to reapply for HSE funding for multiple sclerosis drug
Authorities said in 2012 Fampyra not demonstrably cost-effective for treatment of MS
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices